The manufacturer of Risperdal, Janssen Pharmaceutical Inc., has settled lawsuits against it that claimed the company illegally promoted Risperdal to treat conditions for which the drug does not have FDA approval.
Risperdal is an anti-psychotic that is approved to treat bipolar disorder and schizophrenia. The lawsuits against Janssen, a subsidiary of Johnson & Johnson, allege that the company ghostwrote articles in medical journals to promote it as a reliable treatment for dementia.
The company settled these claims outside of court for $181 million to avoid a lengthy legal battle. Wisconsin is one of 37 states that will receive a part of the settlement, with its share sitting at $4.27 million.
Manufacturers are responsible for marketing their products in a responsible manner that does not confuse consumers. If you have been hurt by a product as a direct result of misleading marketing or labeling, you may be able to seek compensation in a personal injury lawsuit. Contact the product liability attorneys of Habush Habush & Rottier S.C. ® at 800-242-2874 to learn more.